It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.
https://arctichealth.org/en/permalink/ahliterature140532
Source
Scand J Rheumatol. 2011 Mar;40(2):150-2
Publication Type
Article
Date
Mar-2011
More detail
Author
M. Tarkiainen
P. Tynjälä
P. Vähäsalo
P. Lahdenne
Source
Scand J Rheumatol. 2011 Mar;40(2):150-2
Date
Mar-2011
Language
English
Publication Type
Article
Keywords
Adolescent
Antibodies, Monoclonal - adverse effects - therapeutic use
Antirheumatic Agents - adverse effects - therapeutic use
Arthritis, Juvenile - complications - drug therapy - immunology
Child
Female
Finland
HLA-B27 Antigen - blood
Humans
Immunoglobulin G - adverse effects - therapeutic use
Incidence
Inflammatory Bowel Diseases - chemically induced - epidemiology - etiology
Male
Receptors, Tumor Necrosis Factor - therapeutic use
Retrospective Studies
Tumor Necrosis Factor-alpha - antagonists & inhibitors
PubMed ID
20868307
View in PubMed
Less detail
Permalink